(-)-demecolcine increases expression ISO RGD:731488 6480464 Demecolcine results in increased expression of MAP3K8 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731488 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K8 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:731489 6480464 vinylidene chloride results in increased expression of MAP3K8 mRNA CTD PMID:26682919 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of MAP3K8 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP3K8 mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions ISO RGD:731489 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP3K8 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:731488 6480464 Estradiol affects the expression of MAP3K8 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731489 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP3K8 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP3K8 mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731488 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP3K8 mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731489 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K8 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K8 mRNA CTD PMID:22298810 2-hydroxypropanoic acid increases expression ISO RGD:731488 6480464 Lactic Acid results in increased expression of MAP3K8 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:731489 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MAP3K8 mRNA CTD PMID:20188158 , PMID:26251327 4-hydroxyphenyl retinamide increases expression ISO RGD:731489 6480464 Fenretinide results in increased expression of MAP3K8 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:731488 6480464 Decitabine affects the expression of MAP3K8 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine decreases expression ISO RGD:731488 6480464 Decitabine results in decreased expression of MAP3K8 protein CTD PMID:17621267 8-Br-cAMP decreases expression ISO RGD:731488 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAP3K8 mRNA CTD PMID:22079614 adefovir pivoxil increases expression ISO RGD:731488 6480464 adefovir dipivoxil results in increased expression of MAP3K8 mRNA CTD PMID:25596134 afimoxifene decreases response to substance ISO RGD:731488 6480464 MAP3K8 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:731488 6480464 Aflatoxin B1 affects the expression of MAP3K8 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:731488 6480464 Aflatoxin B1 results in decreased methylation of MAP3K8 intron CTD PMID:30157460 aflatoxin B1 increases methylation ISO RGD:731488 6480464 Aflatoxin B1 results in increased methylation of MAP3K8 gene CTD PMID:27153756 albendazole multiple interactions ISO RGD:731488 6480464 [Ivermectin co-treated with Albendazole] results in decreased expression of MAP3K8 mRNA CTD PMID:16861626 all-trans-retinoic acid increases expression ISO RGD:731488 6480464 Tretinoin results in increased expression of MAP3K8 mRNA CTD PMID:21934132 , PMID:23830798 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP3K8 mRNA CTD PMID:16483693 amphibole asbestos increases phosphorylation ISO RGD:731488 6480464 Asbestos, Amphibole results in increased phosphorylation of MAP3K8 protein CTD PMID:23017228 amphibole asbestos multiple interactions ISO RGD:731488 6480464 [Asbestos, Amphibole results in increased secretion of IL1B protein] which results in increased phosphorylation of MAP3K8 protein CTD PMID:23017228 antirheumatic drug decreases expression ISO RGD:731488 6480464 Antirheumatic Agents results in decreased expression of MAP3K8 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:731488 6480464 Arsenic affects the methylation of MAP3K8 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:731488 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MAP3K8 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:731488 6480464 Arsenic affects the methylation of MAP3K8 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:731488 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MAP3K8 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:731489 6480464 arsenite results in increased phosphorylation of and results in increased activity of MAP3K8 protein more ... CTD PMID:19808956 belinostat increases expression ISO RGD:731488 6480464 belinostat results in increased expression of MAP3K8 mRNA CTD PMID:27188386 benzene increases expression ISO RGD:731488 6480464 Benzene results in increased expression of MAP3K8 mRNA CTD PMID:20359517 benzo[a]pyrene increases expression ISO RGD:731489 6480464 Benzo(a)pyrene results in increased expression of MAP3K8 mRNA CTD PMID:22228805 benzo[a]pyrene decreases methylation ISO RGD:731488 6480464 Benzo(a)pyrene results in decreased methylation of MAP3K8 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:731488 6480464 Benzo(a)pyrene affects the methylation of MAP3K8 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731488 6480464 Benzo(a)pyrene results in increased expression of MAP3K8 mRNA CTD PMID:20106945 more ... benzoates increases expression ISO RGD:731488 6480464 Benzoates analog results in increased expression of MAP3K8 mRNA CTD PMID:29472718 bis(2-chloroethyl) sulfide increases expression ISO RGD:731489 6480464 Mustard Gas results in increased expression of MAP3K8 mRNA CTD PMID:15674843 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP3K8 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP3K8 mRNA CTD PMID:30816183 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAP3K8 mRNA CTD PMID:25993096 cadmium dichloride decreases expression ISO RGD:731488 6480464 Cadmium Chloride results in decreased expression of MAP3K8 mRNA CTD PMID:25596134 Calcimycin increases expression ISO RGD:731489 6480464 Calcimycin results in increased expression of MAP3K8 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:731489 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA] CTD PMID:25451590 calcitriol increases expression ISO RGD:731488 6480464 Calcitriol results in increased expression of MAP3K8 mRNA CTD PMID:16002434 carbon nanotube increases expression ISO RGD:731489 6480464 Nanotubes, Carbon analog results in increased expression of MAP3K8 mRNA, Nanotubes, Carbon results in increased expression of MAP3K8 mRNA CTD PMID:25554681 chloroacetaldehyde decreases expression ISO RGD:731488 6480464 chloroacetaldehyde results in decreased expression of MAP3K8 mRNA CTD PMID:25596134 choline multiple interactions ISO RGD:731489 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAP3K8 gene CTD PMID:20938992 cisplatin affects expression ISO RGD:731488 6480464 Cisplatin affects the expression of MAP3K8 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:731488 6480464 Cisplatin results in increased expression of MAP3K8 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:731488 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAP3K8 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:731488 6480464 Cisplatin results in decreased expression of MAP3K8 mRNA CTD PMID:25596134 copper(II) sulfate increases expression ISO RGD:731488 6480464 Copper Sulfate results in increased expression of MAP3K8 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:731489 6480464 Asbestos, Crocidolite results in decreased expression of MAP3K8 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:731488 6480464 Cyclosporine results in decreased expression of MAP3K8 mRNA CTD PMID:25562108 , PMID:27989131 dexamethasone increases expression ISO RGD:731488 6480464 Dexamethasone results in increased expression of MAP3K8 mRNA CTD PMID:25047013 dibutyl phthalate increases expression ISO RGD:731489 6480464 Dibutyl Phthalate results in increased expression of MAP3K8 mRNA CTD PMID:17361019 , PMID:21266533 dichloromethane increases expression ISO RGD:731488 6480464 Methylene Chloride results in increased expression of MAP3K8 mRNA CTD PMID:20359517 dioxygen increases expression ISO RGD:731488 6480464 Oxygen deficiency results in increased expression of MAP3K8 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:731488 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:731488 6480464 MAP3K8 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 doxorubicin decreases expression ISO RGD:731488 6480464 Doxorubicin results in decreased expression of MAP3K8 mRNA CTD PMID:29803840 doxycycline multiple interactions ISO RGD:731489 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K8 mRNA] CTD PMID:18089841 elemental selenium multiple interactions ISO RGD:731488 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:731488 6480464 Selenium results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP3K8 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:731488 6480464 entinostat results in increased expression of MAP3K8 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:731488 6480464 Ethyl Methanesulfonate results in decreased expression of MAP3K8 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:731488 6480464 ethylbenzene results in increased expression of MAP3K8 mRNA CTD PMID:20359517 folic acid multiple interactions ISO RGD:731489 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAP3K8 gene CTD PMID:20938992 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of MAP3K8 mRNA CTD PMID:18499655 furan increases expression EXP 6480464 furan results in increased expression of MAP3K8 mRNA CTD PMID:27387713 Genipin multiple interactions ISO RGD:731489 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K8 mRNA] CTD PMID:22687549 hexadecanoic acid multiple interactions ISO RGD:731488 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP3K8 mRNA CTD PMID:30547786 hydrogen peroxide affects expression ISO RGD:731488 6480464 Hydrogen Peroxide affects the expression of MAP3K8 mRNA CTD PMID:20044591 isoprenaline multiple interactions ISO RGD:731489 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K8 mRNA] CTD PMID:18089841 isoprenaline increases expression ISO RGD:731489 6480464 Isoproterenol results in increased expression of MAP3K8 mRNA CTD PMID:18089841 , PMID:20003209 ivermectin multiple interactions ISO RGD:731488 6480464 [Ivermectin co-treated with Albendazole] results in decreased expression of MAP3K8 mRNA CTD PMID:16861626 L-methionine multiple interactions ISO RGD:731489 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAP3K8 gene CTD PMID:20938992 leflunomide increases expression ISO RGD:731488 6480464 leflunomide results in increased expression of MAP3K8 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:731489 6480464 [Eicosapentaenoic Acid co-treated with procyanidin B3] inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K8 mRNA] more ... CTD PMID:11163183 more ... lipopolysaccharide affects response to substance ISO RGD:731489 6480464 MAP3K8 protein affects the susceptibility to Lipopolysaccharides CTD PMID:11163183 lipopolysaccharide increases expression ISO RGD:731489 6480464 Lipopolysaccharides results in increased expression of MAP3K8 mRNA CTD PMID:22169119 , PMID:22687549 lithium atom increases degradation ISO RGD:731489 6480464 Lithium results in increased degradation of MAP3K8 protein alternative form CTD PMID:19159680 lithium atom multiple interactions ISO RGD:731489 6480464 [Lithium results in increased degradation of NFKB1 protein] inhibits the reaction [NFKB1 protein binds to MAP3K8 protein] more ... CTD PMID:19159680 lithium hydride multiple interactions ISO RGD:731489 6480464 [Lithium results in increased degradation of NFKB1 protein] inhibits the reaction [NFKB1 protein binds to MAP3K8 protein] more ... CTD PMID:19159680 lithium hydride increases degradation ISO RGD:731489 6480464 Lithium results in increased degradation of MAP3K8 protein alternative form CTD PMID:19159680 methotrexate increases expression ISO RGD:731488 6480464 Methotrexate results in increased expression of MAP3K8 mRNA CTD PMID:21678067 methotrexate decreases expression ISO RGD:731488 6480464 Methotrexate results in decreased expression of MAP3K8 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:731488 6480464 Methyl Methanesulfonate results in decreased expression of MAP3K8 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:731488 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MAP3K8 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:731488 6480464 methylmercuric chloride results in increased expression of MAP3K8 mRNA CTD PMID:28001369 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of MAP3K8 mRNA CTD PMID:25380136 nickel dichloride increases expression ISO RGD:731488 6480464 nickel chloride results in increased expression of MAP3K8 mRNA CTD PMID:17312168 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAP3K8 mRNA CTD PMID:22546817 o-xylene increases expression ISO RGD:731488 6480464 2-xylene results in increased expression of MAP3K8 mRNA CTD PMID:20359517 obeticholic acid increases expression ISO RGD:731488 6480464 obeticholic acid results in increased expression of MAP3K8 mRNA CTD PMID:27939613 ochratoxin A decreases expression ISO RGD:731488 6480464 ochratoxin A results in decreased expression of MAP3K8 mRNA CTD PMID:30763683 oleic acid multiple interactions ISO RGD:731488 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP3K8 mRNA CTD PMID:30547786 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP3K8 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:731489 6480464 Acetaminophen affects the expression of MAP3K8 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:731488 6480464 Acetaminophen results in increased expression of MAP3K8 mRNA CTD PMID:26690555 phenylmercury acetate increases expression ISO RGD:731488 6480464 Phenylmercuric Acetate results in increased expression of MAP3K8 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731488 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K8 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:731488 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAP3K8 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:731489 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAP3K8 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:731488 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K8 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:731488 6480464 potassium chromate(VI) results in decreased expression of MAP3K8 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:731489 6480464 Pregnenolone Carbonitrile results in increased expression of MAP3K8 mRNA CTD PMID:28903501 procyanidin B3 multiple interactions ISO RGD:731489 6480464 [Eicosapentaenoic Acid co-treated with procyanidin B3] inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K8 mRNA], procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K8 mRNA] CTD PMID:22169119 progesterone increases expression ISO RGD:731488 6480464 Progesterone results in increased expression of MAP3K8 mRNA CTD PMID:18070364 prostaglandin E2 multiple interactions ISO RGD:731489 6480464 MAP3K8 protein affects the reaction [arsenite results in increased secretion of Dinoprostone] CTD PMID:19808956 protein kinase inhibitor multiple interactions ISO RGD:731488 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K8 mRNA] CTD PMID:28003376 quercetin decreases expression ISO RGD:731488 6480464 Quercetin results in decreased expression of MAP3K8 mRNA CTD PMID:21632981 quinoline decreases activity ISO RGD:731488 6480464 quinoline analog results in decreased activity of MAP3K8 protein CTD PMID:16973359 quinoline decreases activity ISO RGD:731489 6480464 quinoline analog results in decreased activity of MAP3K8 protein CTD PMID:16973359 rac-lactic acid increases expression ISO RGD:731488 6480464 Lactic Acid results in increased expression of MAP3K8 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:731488 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAP3K8 mRNA CTD PMID:19059307 SB 431542 multiple interactions ISO RGD:731488 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:731488 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:731488 6480464 Selenium results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 serpentine asbestos increases phosphorylation ISO RGD:731488 6480464 Asbestos, Serpentine results in increased phosphorylation of MAP3K8 protein CTD PMID:23017228 serpentine asbestos multiple interactions ISO RGD:731488 6480464 [Asbestos, Serpentine results in increased secretion of IL1B protein] which results in increased phosphorylation of MAP3K8 protein CTD PMID:23017228 sertraline increases expression ISO RGD:731488 6480464 Sertraline results in increased expression of MAP3K8 mRNA CTD PMID:24865413 Shikonin multiple interactions ISO RGD:731489 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of MAP3K8 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA] CTD PMID:25451590 sodium arsenate multiple interactions ISO RGD:731488 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of MAP3K8 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:731488 6480464 sodium arsenite results in increased expression of MAP3K8 mRNA CTD PMID:12016162 sodium arsenite increases stability ISO RGD:731488 6480464 sodium arsenite results in increased stability of MAP3K8 mRNA CTD PMID:25493608 sodium dodecyl sulfate increases expression ISO RGD:731488 6480464 Sodium Dodecyl Sulfate results in increased expression of MAP3K8 mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of MAP3K8 mRNA CTD PMID:19281266 sulforaphane decreases expression ISO RGD:731489 6480464 sulforafan results in decreased expression of MAP3K8 mRNA CTD PMID:30529165 sulforaphane decreases expression ISO RGD:731488 6480464 sulforafan results in decreased expression of MAP3K8 mRNA CTD PMID:31838189 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAP3K8 mRNA CTD PMID:20371263 tamoxifen multiple interactions ISO RGD:731488 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K8 mRNA CTD PMID:19059307 toluene increases expression ISO RGD:731488 6480464 Toluene results in increased expression of MAP3K8 mRNA CTD PMID:20359517 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP3K8 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:731488 6480464 Trichloroethylene results in increased expression of MAP3K8 mRNA CTD PMID:20359517 trichostatin A increases expression ISO RGD:731488 6480464 trichostatin A results in increased expression of MAP3K8 mRNA CTD PMID:24935251 tris(2-butoxyethyl) phosphate affects expression ISO RGD:731488 6480464 tris(2-butoxyethyl) phosphate affects the expression of MAP3K8 mRNA CTD PMID:29024780 trovafloxacin multiple interactions ISO RGD:731489 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MAP3K8 mRNA CTD PMID:18930950 valproic acid decreases expression ISO RGD:731488 6480464 Valproic Acid results in decreased expression of MAP3K8 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid multiple interactions ISO RGD:731488 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K8 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731488 6480464 Valproic Acid results in increased expression of MAP3K8 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:731488 6480464 Valproic Acid affects the expression of MAP3K8 mRNA CTD PMID:25979313 vincristine increases expression ISO RGD:731488 6480464 Vincristine results in increased expression of MAP3K8 mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:731488 6480464 Vitamin E results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:731488 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:731488 6480464 vorinostat results in increased expression of MAP3K8 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:731488 6480464 zoledronic acid results in increased expression of MAP3K8 mRNA CTD PMID:24714768 , PMID:25596134
Gene-Chemical Interaction Annotations
